Immune Regulation News 1.09, December 11, 2009. Click here if you are unable to see images in this e-mail.

TOP STORIES

UCLA Researchers Demonstrate that Stem Cells Can Be Engineered to Kill HIV
For the first time, researchers have demonstrated that human blood stem cells can be engineered into a large population of mature, multifunctional HIV-specific CD8 cells that could specifically target cells containing HIV proteins. Potentially, this process could be used against a range of chronic viral diseases. [UCLA AIDS Institute, Los Angeles]
 
Request A Poster  
Isolate Untouched Cells for
Antigen Processing and Presentation
with EasySep®
 
 
REQUEST A POSTER STEMCELL Technologies Inc
 



SPECIAL FEATURE

Video: The EasySep® Pour-off - A Simple and Effective Way to Isolate Cells



SCIENCE NEWS

Screening Method Able to Identify Newborns with Blood Disorder That Affects Immune System
The testing of DNA from a statewide blood screening program for newborns in Wisconsin was able to identify infants with T cell lymphopenia, a blood disorder that affects the child's immune system, a disease in which early identification is important. [Medical College of Wisconsin and Children's Research Institute, Milwaukee]

Potential Cancer Drug May Offer New Hope for Asthma Patients

Scientists found that the drug, R-Roscovitine, helps to kill certain immune cells which can exacerbate symptoms associated with asthma. [University of Edinburgh, Edinburgh]

Request A Sample  
Column-Free Isolation of
Hematopoietic Stem and Progenitor Cells
with EasySep®
 
 
REQUEST A SAMPLE STEMCELL Technologies Inc
 



CURRENT PUBLICATIONS

MicroRNA miR-326 Regulates TH-17 Differentiation and is Associated with the Pathogenesis of Multiple Sclerosis
Researchers identify a TH-17 cell-associated microRNA, miR-326, whose expression was highly correlated with disease severity in patients with multiple sclerosis and mice with experimental autoimmune encephalomyelitis.  [Nat Immunol]

T Cell Receptor CDR3 Sequence but Not Recognition Characteristics Distinguish Autoreactive Effector and Foxp3+ Regulatory T Cells
Results imply that ontogenically distinct regulatory T cell (Treg) and conventional T cell (Tconv) repertoires with convergent specificities for autoantigen respond during autoimmunity and argue against more than limited plasticity between Treg and Tconv cells during autoimmune inflammation. [Immunity]

An Innate Response to Allogeneic Nonself Mediated by Monocytes
Observations indicate that monocytes mount a response to allogeneic nonself, a function not previously attributed to them, and suggest the existence of mammalian innate allorecognition strategies distinct from detection of missing self-MHC molecules by NK cells. [J Immunol]

A Dual Action of Rheumatoid Arthritis Synovial Fibroblast IL-15 Expression on the Equilibrium between CD4+CD25+ Regulatory T Cells and CD4+CD25- Responder T Cells
Fibroblast-like cells from the synovium of rheumatoid arthritis patients exerts a dual action on the equilibrium between regulatory T cell (Treg) and Responder T Cells (Tresp) by potentiating the suppressive effect of Treg while augmenting the proinflammatory action of Tresp; the result is a shift of the Treg/Tresp balance toward a proinflammatory state. [J Immunol]

Depletion of Foxp3+ Cells Leads to Induction of Autoimmunity by Specific Ablation of Regulatory T Cells in Genetically Targeted Mice

Autoimmunity can be reversed by the adoptive transfer of Tregs into depleted murine hosts, and the transfer of Foxp3-deficient bone marrow into T cell-deficient irradiated recipients leads to full-blown disease development. [J Immunol]

Normal Regional Lymph Node Enrichment of Antigen-Specific Regulatory T Cells with Autoimmune Disease-Suppressive Capacity
Natural CD4+CD25+Foxp3+ regulatory T cells (Treg) effectively prevent autoimmune disease development, but their role in maintaining physiological tolerance against self-antigen of internal organs is not yet defined. In this study, researchers quantified disease-specific Treg as Treg that preferentially suppress one autoimmune disease over another in day 3 thymectomized recipients. [J Immunol]

The Human "Treg MLR": Immune Monitoring for Foxp3+ T Regulatory Cell Generation
In the regulatory T cell (Treg) mixed lymphocyte reactions (MLR), the generation of CD4+CD25High Foxp3+ cells is more pronounced in the context of self-recognition (HLA matching, indirect presentation). These cells can be assayed for MLR inhibitory and Treg recruitment functions, so as to immunologically monitor the allospecific regulation after transplantation. [Transplantation]

Book A Demo  
Isolate Cells Directly from
Leukapheresis Products
with the "Easy 50" EasySep® Magnet
 
 
BOOK A DEMO STEMCELL Technologies Inc
 




INDUSTRY NEWS

ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease
In addition to data released in late November, ChemoCentryx, Inc., announced more data from the Company's PROTECT-1 (The Prospective Randomized Oral Therapy Evaluation in Crohn's Disease Trial) of Traficet-EN(TM) in patients with moderate-to-severe Crohn's disease.

MOLOGEN Applies for Phase 2 Clinical Study for Cancer Drug MGN 1703
MOLOGEN AG has applied to the responsible authorities and ethics committees in Germany and Austria to carry out a phase 2 clinical study with its cancer drug MGN1703 for the treatment of metastasized colorectal cancer.


POLICY NEWS

NIAID Trial of 2009 H1N1 Influenza Vaccine Enrolling HIV-Positive Adults
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.



EVENTS

9th International Conference on New Trends in Immunosuppression and Immunotherapy
February 4-6, 2010
Geneva, Switzerland

13th International Conference on Lymphocyte Activation and Immune Regulation: Inflammasome and Inflammation
February 5-7, 2010
Newport Beach, United States

Keystone Symposia: Tolerance and Autoimmunity
February 21-26, 2010
Taos, United States

World Immune Regulation Meeting - IV
March 29-April 1, 2010
Davos, Switzerland

IMMUNOLOGY 2010
May 7-11, 2010
Baltimore, United States

14th International Congress of Immunology
August 22-27, 2010
Kobe, Japan

Visit our events page  to stay up to date with the latest events in the cell, gene and immunotherapy community.


JOB OPPORTUNITIES

Technical Specialist (AABB)

Research & Development Scientist - Mesenchymal Cell Biology (STEMCELL Technologies)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
Visit here to post your career opportunities.


Have we missed an important article or publication in Immune Regulation News? Click here to submit!

 
forwardafriendicon